Concepedia

Guido Ghilardi

GG

Statistics

Publications

20

Citations

1.5K

H-Index

16

Active since

2015

Affiliations

University of Pennsylvania(Current)

Hospital of the University of Pennsylvania

UPMC Hillman Cancer Center

Institute of Oncology Research

Parker Institute for Cancer Immunotherapy

Guido Ghilardi is an author at University of Pennsylvania specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2015–2025

20

Publications

20

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Melody Smith, Anqi Dai, Guido Ghilardi et al. · Nature Medicine · 2022 · 309 citations · Full text

, , +14

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Guido Ghilardi, Joseph A. Fraietta, James N. Gerson et al. · Nature Medicine · 2024 · 256 citations

, , +16

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli et al. · Blood · 2015 · 215 citations · Full text

, , +13

Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer

Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi et al. · Cancer Discovery · 2022 · 98 citations · Full text

, , +16

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti et al. · Blood · 2021 · 97 citations · Full text

, , +17

1–5 of 20